CNBC's Inside India newsletter: Will India's lofty manufacturing ambitions bear fruit?
As the 10th anniversary of the Make in India initiative nears, CNBC’s Inside India takes a look at how the nation’s ...
ENDPOINTS NEWS3d
As­cendis aims to raise $300M; Basilea inks up to $268M deal with BAR­DA
Plus, news about GSK, Novo Nordisk, Tanai Therapeutics, Nomic Bio, Brenus Pharma, Xspray, Achilles Therapeutics, BioXcel Therapeutics and Nuvalent: Ascendis’ $300M offering: The Danish company ...
BioPharma Dive4d
Novartis’ Kisqali gets expanded FDA OK; Mene Pangalos joins Omega Funds
The FDA’s clearance could double Kisqali’s breast cancer market. Elsewhere, Novo is exploring new ways to deliver genetic therapies and Bain is funding a growing CDMO.
FiercePharma5d
With amped up manufacturing effort, Sanofi and AZ look to avoid Beyfortus shortfalls this year
Sanofi and development and manufacturing lead AstraZeneca continue to work together ... The company plans to be "more ...
Kingfisher lifts lower end of guidance, GSK's Blenrep accepted for review in Japan
London open The FTSE 100 is expected to open 54 points higher on Tuesday, having closed up 0.07% on Monday at 8,278.44.
Sarepta Therapeutics Appoints Deirdre Connelly to its Board of Directors
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the ...